Exact Mass: 577.1512233999999

Exact Mass Matches: 577.1512233999999

Found 19 metabolites which its exact mass value is equals to given mass value 577.1512233999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Clazosentan

N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-1,2,3,4-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulphonamide

C25H23N9O6S (577.1491938)


C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].

   
   
   

sodium 4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

sodium 4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

C25H24N5NaO6S2 (577.1065644)


   
   
   

NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE

NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE

C19H34NNa2O14P (577.1512233999999)


   

NEU5AC ALPHA(2-3)GAL BETA MP GLYCOSIDE

NEU5AC ALPHA(2-3)GAL BETA MP GLYCOSIDE

C24H35NO15 (577.2006600000001)


   

Clazosentan

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methyl-pyridine-2-sulfonamide

C25H23N9O6S (577.1491938)


C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].

   
   

pelargonidin 3-O-beta-D-p-coumaroylglucoside

pelargonidin 3-O-beta-D-p-coumaroylglucoside

C30H25O12- (577.134595)


   

cicerin-7-O-glucoside-6-malonate

cicerin-7-O-glucoside-6-malonate

C26H25O15- (577.11934)


   

6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate

6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate

C27H29O14- (577.1557233999999)


   

2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester

2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester

C29H25ClFN5O5 (577.1528162)


   

(3S,3S,4R,5S)-5-(2-hydroxyethyl)-5-iodo-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-1-prop-2-enyl-2-spiro[indole-3,2-oxolane]one

(3S,3S,4R,5S)-5-(2-hydroxyethyl)-5-iodo-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-1-prop-2-enyl-2-spiro[indole-3,2-oxolane]one

C26H32INO4Si (577.1145262)


   

vitexin 2-O-alpha-L-rhamnoside(1-)

vitexin 2-O-alpha-L-rhamnoside(1-)

C27H29O14- (577.1557233999999)


The conjugate base of vitexin 2-O-alpha-L-rhamnoside arising from deprotonation of the OH group at position 7 on the chromene.

   

vitexin 2-O-beta-L-rhamnoside(1-)

vitexin 2-O-beta-L-rhamnoside(1-)

C27H29O14 (577.1557233999999)


A flavonoid oxoanion that is the conjugate base of vitexin 2-O-beta-L-rhamnoside obtained by deprotonation of the OH group at position 7 on the chromene. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

n-[(2r,3r,4r,5r,6s)-3-(acetyloxy)-6-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-5-hydroxy-2-methyloxan-4-yl]ethanimidic acid

n-[(2r,3r,4r,5r,6s)-3-(acetyloxy)-6-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-5-hydroxy-2-methyloxan-4-yl]ethanimidic acid

C31H31NO10 (577.1947866)